image
Ionis Pharmaceuticals, Inc. IONS
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 34.34
-7.76 %
$ 5.42 B
Market Cap
-14.07
P/E
INCOME STATEMENT
788 M REVENUE
34.18%
Growth Rates
1Year 34.18%
3Years 2.61%
5Years 5.60%
7Years 12.44%
10Years 18.25%
-354 M OPERATING INCOME
13.93%
Growth Rates
1Year 13.93%
3Years -27.17%
5Years -41.95%
7Years -33.70%
10Years -21.21%
-366 M NET INCOME
-35.80%
Growth Rates
1Year -35.80%
3Years 9.04%
5Years -22.01%
7Years -22.89%
10Years -19.70%
EFFICIENCY
Earnings Waterfall Ionis Pharmaceuticals, Inc.
image
Revenue 788 M
Cost Of Revenue 9.13 M
Gross Profit 779 M
Operating Expenses 780 M
Operating Income -354 M
Other Expenses 12.6 M
Net Income -366 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000 Dec-1999 Dec-1998 Dec-1997 Dec-1996 Dec-1995 Dec-1994 Dec-1993 Dec-1992 Dec-1991 Dec-1990
REVENUE
Revenue 787.6 587.0 810.0 729.0 1 123.0 599.7 507.7 346.6 283.7 214.2 147.3 102.0 99.1 108.5 121.6 107.2 69.6 24.5 40.1 42.6 50.0 80.2 53.3 37.3 33.9 39.2 32.5 22.6 13.0 10.1 12.1 8.7 6.3 2.0
GROSS PROFIT
Cost Of Revenue 9.1 14.0 11.0 12.0 4.0 1.8 374.6 344.3 322.3 241.8 184.0 158.5 0 0 0 0 0 0 0 0 0 0 0 (5.5) (5.2) (4.3) (3.2) (2.6) (2.8) (3.8) 22.4 (2.0) 11.5 4.4
Gross Profit 778.5 573.0 799.0 717.0 1 119.0 597.9 133.0 2.3 (38.6) (27.6) (36.7) (56.4) 99.1 108.5 121.6 107.2 69.6 24.5 40.1 42.6 50.0 80.2 53.3 42.8 39.1 43.5 35.7 25.2 15.8 13.9 (10.3) 10.7 (5.2) (2.4)
OPERATING INCOME
Operating Expenses 779.6 984.0 829.0 889.0 753.0 659.2 483.1 392.9 359.5 261.9 199.0 171.0 170.2 156.8 149.1 120.2 108.6 93.2 90.4 128.1 127.2 129.6 99.4 71.8 82.2 76.0 67.2 54.5 41.4 36.4 8.0 32.3 5.3 2.1
Selling, General and Administrative Expenses 232.6 151.0 186.0 354.0 287.0 244.6 108.5 48.6 37.2 20.1 14.9 12.5 12.8 11.7 14.5 13.8 15.9 12.6 7.9 9.6 10.2 5.5 15.6 9.2 10.6 9.5 8.1 6.2 5.4 6.0 4.8 30.3 4.4 1.7
Research and Development Expenses 899.6 833.0 643.0 535.0 466.0 414.6 374.6 344.3 322.3 241.8 184.0 158.5 157.4 145.2 134.6 106.4 92.6 80.6 82.5 118.5 117.0 124.1 83.7 57.0 66.4 62.2 55.9 45.7 33.2 26.5 0 0 0 0
Operating Income (353.7) (411.0) (30.0) (172.0) 366.0 (61.4) 24.5 (46.3) (75.8) (47.7) (51.7) (68.9) (71.1) (48.4) (27.5) (13.1) (38.9) (68.1) (57.2) (117.9) (79.0) (50.8) (46.1) (29.0) (43.1) (32.5) (31.5) (29.3) (25.6) (22.5) (18.3) (21.6) (10.5) (4.5)
PRE-TAX INCOME
Interest Income Expense 81.5 8.1 4.3 45.0 49.0 44.8 44.8 38.8 36.7 22.2 19.4 21.2 16.7 13.2 12.7 11.8 (7.6) (9.0) (20.3) (22.6) (18.7) (16.6) (15.2) 0 0 0 0 0 0 0 0 0 0 0
Total Other Income 19.8 152.2 1.0 37.5 (27.1) (14.8) (47.8) (37.3) (12.1) (6.7) (14.9) (5.7) (13.7) (12.8) (4.2) (1.0) 28.0 (3.7) (15.2) (24.6) (16.0) (21.4) (27.7) (17.9) (7.2) (1.0) 3.9 3.8 3.0 5.5 0 2.1 1.8 0
Pre-Tax Income (334.0) (258.0) (30.0) (170.0) 347.0 (76.2) (23.3) (83.6) (87.9) (54.4) (66.6) (74.6) (84.8) (61.2) (31.8) (14.0) (11.0) (65.3) (72.4) (142.5) (95.0) (72.2) (73.8) (46.8) (50.3) (33.5) (27.4) (25.3) (22.6) (17.0) 0 (19.5) (8.7) 0
NET INCOME
Tax Provision 32.3 12.0 (1.0) 317.0 44.0 (291.1) (6.0) 2.9 0.4 (15.4) (5.9) (9.1) 11 K 92 K 3.2 (1.1) (28.0) (22.8) 22.2 57.1 17.8 6.8 8.9 24.5 16.1 10.5 (0.4) (2.8) (1.9) (4.3) 0.8 (2.1) (1.8) 0
Net Income (366.3) (270.0) (29.0) (487.0) 294.0 273.7 (6.0) (86.6) (88.3) (39.0) (60.6) (65.5) (84.8) (61.3) 155.1 (12.0) (11.0) (45.9) (72.4) (142.5) (95.0) (72.2) (73.8) (53.5) (59.2) (43.0) (31.1) (26.5) (23.7) (18.2) (19.1) (19.5) (8.7) (4.5)
EPS 2.56 1.9 0.21 3.49 2.1 2.07 0.0481 0.72 0.74 0.33 0.55 0.65 0.85 0.62 1.58 0.13 0.13 0.62 1.15 2.52 1.71 1.33 1.67 1.44 2.06 1.6 1.17 1.04 1.1 0.93 1.22 1.51 0.84 0.7